MEDIFRON DBT
Medifron DBT researches and develops pharmaceuticals for neuropathic pain, agonists and others. The Company also engages in sale of pharmaceuticals and patent license businesses. The other business division provides real-time voice contents for Internet services and distributes computer peripheral such as LCD monitor, printer, and mouse, through online shopping malls.
MEDIFRON DBT
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1997-03-18
Address:
Geumgok, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.medifron.com
Total Employee:
51+
Status:
Active
Contact:
(822) 545-9277
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Content Delivery Network Font Awesome JsDelivr Cloudflare JS CDN JS AJAX Libraries API
Similar Organizations
Bio-Cancer Treatment
Bio-Cancer Treatment is a clinical-stage biopharmaceutical company focused on the research and development of innovative biologics.
Official Site Inspections
http://www.medifron.com Semrush global rank: 4.85 M Semrush visits lastest month: 1.83 K
- Host name: 139.150.65.217
- IP address: 139.150.65.217
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Medifron DBT"
INVESTMENT TREND 2024: INVEST SEOUL - medifron.com
Warm Greetings from Invest Seoul! It is our great pleasure to invite you to the upcoming โTrend & Investment Seminar 2024โ scheduled to be held on August 26th, 2024 This event includes โฆSee details»
๋ฉ๋ํ๋ก ๋๋นํฐ - medifron.com
[ ๋ฉ๋์ปฌํฌ๋ฐ์ด ] ๋ฉ๋ํ๋ก , ๋ฒค์ฒ๊ธฐ์ ์ธ์ฆ ํ๋. 2018.06.2194 [ business post ] ๊น์ํธ, ๋ฉ๋ํ๋ก ์ ์น๋งค ์ง๋จ๊ธฐ๊ธฐ ๊ฐ๋ฐ ๋ฌต๋ฌตํ ๊ฐ๋คSee details»
๋ฉ๋ํ๋ก ๋๋นํฐ - medifron.com
์ ์ฃผ๋ฐฐ์ ๊ธฐ์ค์ผ ๋ฐ ์ฃผ์๋ช ์๊ฐ์ ์ ์ง๊ณต๊ณ . 2017.09.22; ์ 20๊ธฐ ๊ฒฐ์ฐ๊ณต๊ณ . 2017.03.30; ์ ๊ธฐ์ฃผ์ฃผ์ดํ ๊ฒฐ๊ณผ. 2017.03.27; ์ 20๊ธฐ ์ ๊ธฐ์ฃผ์ฃผ์ดํ ์์ง ๊ณต๊ณ See details»
Medifron DBT Co.,Ltd. (South Korea) - EMIS
Jul 23, 2024ย ยท Report with financial data, key executives contacts, ownership details & and more for Medifron DBT Co.,Ltd. in South Korea. Report is available for immediate purchase & โฆSee details»
Medifron Dbt Co., Ltd., #1401 A-dong Woolim Blue9... - Kompass
Medifron DBT, Inc. is a clinical stage biopharmaceutical company focusing on the development of Alzheimer's disease (AD) and neuropathic pain (NP) treatment and AD diagnostics.See details»
Medifron - Company Profile - Tracxn
Oct 20, 2024ย ยท Medifron is a clinical stage company focused on the development of drugs and diagnostic tests for CNS disorders. Its pipeline programs include MDR-16523 & MDR-652, a โฆSee details»
About Hyper Corporation Inc (065650) - Investing.com
Get an in-depth profile of Hyper Corporation Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.See details»
Medifron DBT Co., Ltd. announced that it has received KRW 8 โฆ
Dec 7, 2020ย ยท Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion. On December 8, 2020, Medifron DBT Co., Ltd. closed the โฆSee details»
Medifron DBT - Products, Competitors, Financials, Employees ...
Medifron DBT is a biotechnology company focused on the development of treatments and diagnostic tools for Alzheimer's disease and non-narcotic pain relief. Use the CB Insights โฆSee details»
๋ฉ๋ํ๋ก /ํํ๋งคํธ๋ฆญ์ค ์น๋งค ์กฐ๊ธฐ ์ง๋จ ํคํธ ์ด๋ฒ์ ์ ๋ง ๋์ค๋๊ฑธ๊น
Jul 29, 2020ย ยท ๋ฉ๋ํ๋ก ๊ตญ๋ฌธ ํํ์ด์ง์๋ ๋ค ๊ฐ์ง ์นดํ ๊ณ ๋ฆฌ์ ํ์ดํ๋ผ์ธ์ ํ์ธํ ์ ์๋ค. ์งํ์ํฉ์ ์๊ฐ๋ณด๋ค ์ง์ง๋ถ์งํ ๋ฏ. http://www.medifron.com/ko/m2/index.asp?mode=m1. โฆSee details»
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs โฆ
Apr 4, 2024ย ยท Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. on April 5, 2024....See details»
Medifron DBT Co. Ltd. - BioCentury Company Profiles - BCIQ
Medifron DBT Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
INVESTMENT TREND 2024: INVEST SEOUL - medifron.com
It is our great pleasure to invite you to the upcoming โFintech Trend & Investment Seminar 2024โ scheduled to be held on December 12th, 2024 This event includes seminars on overall insight โฆSee details»
Medifron DBT Co., Ltd. announced that it has received KRW โฆ
May 11, 2020ย ยท Global Tax Free Co., Ltd. acquired additional 7.5% stake in Swanicoco Co., Ltd. from Brain Contents CO., LTD. for KRW 25.7 billion. On May 12, 2020, Medifron DBT Co., Ltd. โฆSee details»
๋ฉ๋ํ๋ก 065650, ์ฝ์ค๋ฅ NO.935 - ์ฃผ์ ๊ณต๋ถ๋ฐฉ!
Jun 23, 2021ย ยท https://www.medifron.com/ko/index.asp ๋ฉ๋ํ๋ก ๋๋นํฐ (์ฃผ)๋ฉ๋ํ๋ก ์ ์์ธ ํ์ด๋จธ์ฑ ์น๋งค์น๋ฃ์ ์ ์น๋งค์กฐ๊ธฐ์ง๋จํคํธ, ๋น๋ง์ฝ์ฑ์งํต์ ๋ฅผ ๊ฐ๋ฐํ๊ณ ์๋ โฆSee details»
Medifron DBT Co Ltd. | Institution outputs | Nature Index
Jul 1, 2023ย ยท The Nature Index 2024 Research Leaders โ previously known as Annual Tables โ reveal the leading institutions and countries/territories in the natural and health sciences, โฆSee details»
Medifron DBT Co., Ltd. announced that it expects to receive KRW โฆ
Feb 19, 2020ย ยท Medifron DBT Co., Ltd. (KOSDAQ:A065650) announced a private placement of 2,850,478 shares at a price of KRW 3,859 per share for gross proceeds of KRW โฆSee details»
mu opioid receptor agonists (Medifron) - Drug Targets, Indications ...
Methadone is a mu (ฮผ) opioid receptor agonist used clinically in adults and children to manage opioid use disorder, neonatal abstinence syndrome, and acute and chronic pain. It is typically โฆSee details»
Medifron DBT Co., Ltd. announced that it has received KRW 4 โฆ
On September 15, 2021, Medifron DBT Co., Ltd. closed the transaction. ... (KOSDAQ:A065650) dropped from S&P Global BMI Index 22-09-19: CI Medifron DBT Co., Ltd. announced that it โฆSee details»
Medifron DBT Co., Ltd. announced that it expects to receive KRW 8 ...
Nov 29, 2020ย ยท Medifron DBT Co., Ltd. (KOSDAQ:A065650) announced a private placement of series 9 domestic unregistered non-guaranteed private convertible bond for gross proceeds of โฆSee details»